Literature DB >> 10072231

Myocardial adenine nucleotides, glycogen, and Na, K-ATPase in patients with idiopathic dilated cardiomyopathy requiring mechanical circulatory support.

K Ishino1, H E Bøtker, T Clausen, R Hetzer, J Sehested.   

Abstract

Acute decompensation leading to progressive pump failure is a main cause of death in patients with congestive heart failure. To find possible metabolic defects associated with the onset of this fatal occurrence, we measured myocardial adenine nucleotides, glycogen, and Na,K-ATPase in patients with end-stage idiopathic dilated cardiomyopathy. The biopsy specimens were obtained from the right ventricle of beating hearts during implantation of a biventricular assistance device in 23 patients (group I) suffering from irreversible cardiogenic shock and during heart transplantation in 20 patients (group II) in compensated heart failure. Left ventricular ejection fraction (LVEF) was determined preoperatively by echocardiography. Left ventricular function in group I was more severely impaired than in group II (LVEF 16.8%+/-4.6% vs 22.1%+/-5.1 %; p <0.01). Myocardial adenosine triphosphate (ATP) in group I was significantly reduced in comparison with group II (119.4+/-10.2 vs 27.7+/-7.4 nmol/mg noncollagen protein; p <0.01). There was no difference in glycogen levels. Na,K-ATPase concentration in group I (n = 8) was lower than that of group II (n = 20) (425+/-80 vs 498+/-75 pmol/g wet weight; p <0.05). Linear regression analyses showed a significant correlation between adenosine triphosphate (ATP) and LVEF (r = 0.41, p <0.01) and between Na,K-ATPase and LVEF (r = 0.55, p <0.01). These results indicate that loss of myocardial ATP and Na,K-ATPase could partially contribute to the development of spontaneous deterioration of the chronically overloaded heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072231     DOI: 10.1016/s0002-9149(98)00876-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Myocardial Na,K-ATPase: Clinical aspects.

Authors:  Keld Kjeldsen
Journal:  Exp Clin Cardiol       Date:  2003

2.  Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit.

Authors:  Sonali P Barwe; Maria C Jordan; Anna Skay; Landon Inge; Sigrid A Rajasekaran; Daniel Wolle; Christina L Johnson; Patricia Neco; Kun Fang; Nora Rozengurt; Joshua I Goldhaber; Kenneth P Roos; Ayyappan K Rajasekaran
Journal:  J Mol Cell Cardiol       Date:  2009-08-15       Impact factor: 5.000

3.  Gene module regulation in dilated cardiomyopathy and the role of Na/K-ATPase.

Authors:  Yingnyu Gao; Lilian N D Silva; John D Hurley; Xiaoming Fan; Sandrine V Pierre; Komal Sodhi; Jiang Liu; Joseph I Shapiro; Jiang Tian
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

4.  Na/K-ATPase signaling mediates miR-29b-3p regulation and cardiac fibrosis formation in mice with chronic kidney disease.

Authors:  Christopher A Drummond; Xiaoming Fan; Steven T Haller; David J Kennedy; Jiang Liu; Jiang Tian
Journal:  PLoS One       Date:  2018-05-18       Impact factor: 3.240

5.  DR region of Na+-K+-ATPase is a new target to protect heart against oxidative injury.

Authors:  Fei Hua; Zhiyuan Wu; Xiaofei Yan; Jin Zheng; Haijian Sun; Xu Cao; Jin-Song Bian
Journal:  Sci Rep       Date:  2018-08-30       Impact factor: 4.379

6.  Characterization of a Long Non-Coding RNA, the Antisense RNA of Na/K-ATPase α1 in Human Kidney Cells.

Authors:  Xiaoming Fan; Usman M Ashraf; Christopher A Drummond; Huilin Shi; Xiaolu Zhang; Sivarajan Kumarasamy; Jiang Tian
Journal:  Int J Mol Sci       Date:  2018-07-21       Impact factor: 5.923

Review 7.  The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?

Authors:  Jiang Liu; Jiang Tian; Komal Sodhi; Joseph I Shapiro
Journal:  J Membr Biol       Date:  2021-07-23       Impact factor: 1.843

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.